Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1998-10-23
2002-05-28
Nguyen, Dave T. (Department: 1632)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S320100, C536S023100, C536S023500, C536S024310
Reexamination Certificate
active
06395477
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to novel polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic, and research utilities for these polynucleotides and proteins. In particular, the present invention relates to the identification of a novel human voltage-gated potassium channel polynucleotide, Kv4.3, and isoforms thereof, polypeptides encoded by them, and their uses.
BACKGROUND OF THE INVENTION
Mammalian cell membranes are important to the structural integrity and activity of many cells and tissues. Of particular interest in membrane physiology is the study of trans-membrane ion channels which act to directly control a variety of pharmacological, physiological, and cellular processes. Numerous ion channels have been identified including calcium, sodium, and potassium channels, each of which have been investigated to determine their roles in vertebrate and insect cells.
Because of its involvement in maintaining normal cellular homeostasis, much attention has been given to potassium channels. A number of these potassium channels open in response to changes in the cell membrane potential. Many voltage-gated potassium channels have been identified are characterized by their electrophysiological and pharmacological properties. Potassium currents are more diverse than sodium or calcium currents and are further involved in determining the response of a cell to external stimulus. The diversity of potassium channels and their important physiological role highlights their potential as targets for developing therapeutic agents for various diseases.
One of the best characterized class of potassium channels are the voltage-gated potassium channels. The prototypical member of this class is the protein encoded by the Shaker gene in Drosophila melanogaster. In addition to Shaker, three other classes of potassium channels. Shap, Shaw, and Shal have been identified in Drosophila Proteins of the Shal or or the mammalian Kv4 family are a type of voltage-gated potassium channels that underlies many of the native A type currents that have been recorded from different primary cells (Serodio et al. 1994,1998; Dixon et al. 1996). The Kv4 channel has a major role in the repolarization of cardiac atrial action potentials (Dixon et al. 1996). In neurons, Kv4 channels and the A currents they may comprise play an important role in modulation of firing rate, action potential initiation and in shaping burst pattern (Byrne 1980; Connor and Stevens 1971; Getting 1983; Hille 1992; Llinas 1988; McCormick and Huguenard 1992; Rudy 1988; Thompson and Aldrich 1980). Recently, A currents were localized to dendritic regions in the hippocampus where they play a complex role in modulating synaptic input and retrograde propagation of action potentials (Hoffman et al. 1997).
The gene encoding rat Kv4.3 channels have been cloned and expressed by several labs (Dixon et al. 1996; Serodio et al. 1996; Ohya et al. 1997 and Takimoto et al. 1997). The identification of the Kv4 family as the molecular correlate for the transient outward potassium current (also called the A current) in both heart and brain comes primarily from data obtained with Xenopus oocytes expressing rat Kv4 cloned channels. As in native neurons and myocytes, Kv4 channels display fast and complete inactivation at positive potentials. Initially however, the voltage dependency for steady-state activation and inactivation of these expressed Kv4 channels appeared to be shifted 20 mV positive to that seen in neurons, which would place them out of the subthreshold category. In addition the recovery from inactivation of the expressed channels was slower than that seen in the native cells. Fortunately it was discovered that addition of a low molecular weight RNA fraction from rat brain, presumably containing a beta subunit for the Kv4 channel, shifted the voltage dependence and speeds the channels rate of recovery from inactivation to that seen in the native cells (Serodio et al. 1994, 1996 and Chabala et al. 1993). Further confirmation of the role of Kv4 channels in forming A type currents comes from antisense hybrid-arrest and dominant-negative experiments in both neurons and cardiac myocytes (Johns et al. 1997; Fiset et al. 1997; Nakamura et al. 1997).
Until the present invention, the gene encoding human Kv4.3 had not been identified. The art needs molecular characterization of the human Kv4.3 channel in order to elucidate their function and properties in preventing or treating dysfunctions and diseases.
SUMMARY OF THE INVENTION
This invention provides novel isolated polynucleotides which encode human Kv4.3 potassium channel polypeptides. The polynucleotides of the present invention are isolated from human brain and heart and further comprise (a) polynucleotide comprising the potassium channel Kv4.3 nucleotide sequence set forth in SEQ. ID NO. 1 or in SEQ. ID NO. 3; (b) a polynucleotide having at least 90% identity over its entire length to a polynucleotide encoding a potassium channel Kv4.3 polypeptide of SEQ ID NO: 2 or SEQ ID NO: 4; (c) a polynucleotide which is an allelic variant of the polynucleotide of (a)-(b) above; and (d) a polynucleotide capable of hybridizing under stringent conditions to any one of the polynucleotides specified in (a)-(c).
Preferably such polynucleotides comprise the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 3.
In other embodiments, the present invention provides a composition comprising a Kv4.3 polypeptide, wherein said polypeptide comprises (a) an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4.
Preferably such polypeptides comprise the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4.
In certain preferred embodiments, the Kv4.3 polynucleotide is operably linked to an expression control sequence. The invention also provides a host cell, including bacterial, yeast, insect, amphibian and mammalian cells, transformed with such polynucleotides compositions.
Processes are also provided for producing Kv4.3 polypeptides.
Compositions comprising an antibody which specifically reacts with the polypeptide are also provided by the present invention.
Methods and diagnostic processes are provided for detecting a disease state characterized by aberrant expression of Kv4.3 polypeptides, as well as methods for identifying compounds which regulate the activity or expression of the polypeptides.
Another embodiment of the invention includes transgenic animals comprising a polynucleotide encoding a human Kv4.3 polynucleotide operably linked to an expression control sequence.
REFERENCES:
patent: WO9842833 (1998-01-01), None
Al Lehninger et al., Principles of Biochemistry with an Extended Discussion of Oxygen-Binding Proteins, 2nd, Edition, (Worth Publishers, New York, NY), Chap.25 RNA Metabolism, p. 867, 1993.*
Mullins JJ et al. Hypertension 22:630-633, 1993.*
Cameron ER. Molecular Biotechnology 7:253-265, 1997.*
Hammer RE et al. Cell 63:1099-1112 1990.*
Seidel GE. J. Anim. Sci. 71(Suppl. 3):26-33, 1993.*
Kong W and Tomaselli GF GenBank accession No. AF048713, Mar. 6, 1998.*
Faraci FM and Sobey CG, Clin Exp Pharmacol Physiol . 23:1091-5, 1996 (abstract only).*
Serodio, E. et al, Cloning of a Novel Component of A-Type K+ Channels Operating at Subthreshold Potentials With Unique Expression in Heart and Brain, Journal of Neurophysiology, vol. 75, No. 5 pp. 2174-2179 (1996).
Dixon, J., et al., Role of the Kv4.3 K+ Channel in Ventricular Muscle, Circulation Research vol. 79, No. 4 pp. 659-668 (1996).
Dilks, D., et al., Cloning and Expression of the Human Kv4.3 Potassium Channel, Rapid Communication Journal of Neurophysiology vol. 81: 1974-1977, 1999.
Ohya, S., et al., Molecular Cloning and Tissue Distribution of an Alternatively Spliced Variant of an A-type K+ Channel &agr;-subunit, Kv4.3 in the Rat, FEBS Letters 420:pp. 47-53 (1997).
Cockett Mark Ian
Dilks Daniel Wayne
Ling Huai-Ping Chang
Sokol Patricia Tyson
American Home Products Corporation
Bogle Gavin
Nguyen Dave T.
Shukla Ram R.
LandOfFree
Human potassium channel polynucleotide and polypeptides and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human potassium channel polynucleotide and polypeptides and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human potassium channel polynucleotide and polypeptides and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2899145